Breakfast Symposiums
Friday, 21 August 2025 @ 07:00
Eucerin | Beiersdorf
Breakfast Symposium
Title: Redefining Hyperpigmentation Treatment: Evidence, Consensus & Safer Alternatives
A concise exploration of the published Global Consensus on Hyperpigmentation, including Thiamidol’s unique recognition as the only dermocosmetic active. The session will highlight emerging clinical evidence supporting safer, well tolerated alternatives for long term management, with insights tailored to melanin rich skin. Practical guidance will help dermatologists integrate these recommendations into everyday practice.
Speakers:
Prof Ncoza Dlova
Dr Thierry Passeron (France, virtual presentation)
Galderma
Breakfast Symposium
Title: Galderma SKIN Symposium
Topic: START the Journey with Trifarotene: Clinical Evidence Meets Real Results in Acne & Acne Scarring.
Speaker:
Dr Willie Visser
Adcock Ingram / GSK
Breakfast Symposium
Title: Shingles: Just a Rash?
Topic: Join us as we explore herpes zoster in the South African context,
including diagnostic challenges and the role of prevention in key patient
populations.
Speaker:
To be confirmed
Saturday, 22 August 2025 @ 07:00
Genop
Breakfast Symposium
Title: Launch of AKTUVA from Cantabria Labs
Topic: The latest innovation for prevention and adjuvant treatment of actinic
keratoses and non-melanoma forms of skin cancer.
Speaker:
Dr Sian Hartshorne
L'Oréal
Breakfast Symposium
Title: Ceramide-Barrier Science Symposium: New Clinical Evidence in Atopic Skin and Diabetic Xerosis
Topics and speakers:
- The Invisible Barrier Crisis: Subclinical Skin Barrier Dysfunction in Non-Lesional Atopic Skin
Speaker: Dr Lauren Knight - Ceramide Moisturiser as Monotherapy in Mild-to-Moderate AD: What Does the Mega-Analysis Tell Us?
Speaker: Dr Zena Malinga - The Forgotten Complication of Diabetic Skin: New Expert Consensus on Xerosis & Skin Barrier Management.
Speaker: Prof Frans Maruma
Glenmark
Breakfast Symposium
Topic: Skin Barrier First: The Foundation of Dermatology across Eczema, Acne and Sensitive Skin
Speakers:
To be confirmed